1.84
10.18%
+0.17
Pre-market:
1.92
0.08
+4.35%
22nd Century Group, Inc. stock is currently priced at $1.84, with a 24-hour trading volume of 1.00M.
It has seen a +10.18% increased in the last 24 hours and a +1,253% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.65 pivot point. If it approaches the $1.83 resistance level, significant changes may occur.
Previous Close:
$1.67
Open:
$1.68
24h Volume:
1.00M
Market Cap:
$10.31M
Revenue:
$32.20M
Net Income/Loss:
$-140.78M
P/E Ratio:
-0.3472
EPS:
-5.3
Net Cash Flow:
$-60.60M
1W Performance:
+12.88%
1M Performance:
+1,253%
6M Performance:
+269.48%
1Y Performance:
+165.32%
22nd Century Group, Inc. Stock (XXII) Company Profile
Name
22nd Century Group, Inc.
Sector
Industry
Phone
716-270-1523
Address
8560 Main Street, Williamsville, NY
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-21-22 | Initiated | Alliance Global Partners | Buy |
Jun-15-22 | Initiated | Craig Hallum | Buy |
Mar-08-22 | Initiated | ROTH Capital | Buy |
Jul-23-21 | Initiated | Cowen | Outperform |
Oct-16-17 | Reiterated | Chardan Capital Markets | Buy |
Aug-11-16 | Reiterated | Chardan Capital Markets | Buy |
View All
22nd Century Group, Inc. Stock (XXII) Latest News
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Benzinga
22nd Century Group, Inc. Stock (XXII) Financials Data
22nd Century Group, Inc. (XXII) Revenue 2024
XXII reported a revenue (TTM) of $32.20 million for the quarter ending December 31, 2023, a -20.49% decline year-over-year.
22nd Century Group, Inc. (XXII) Net Income 2024
XXII net income (TTM) was -$140.78 million for the quarter ending December 31, 2023, a -135.41% decrease year-over-year.
22nd Century Group, Inc. (XXII) Cash Flow 2024
XXII recorded a free cash flow (TTM) of -$60.60 million for the quarter ending December 31, 2023, a -7.95% decrease year-over-year.
22nd Century Group, Inc. (XXII) Earnings per Share 2024
XXII earnings per share (TTM) was -$114.59 for the quarter ending December 31, 2023, a -61.31% decline year-over-year.
About 22nd Century Group, Inc.
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. In addition, it engages in contract manufacturing business for third-party branded tobacco products. The company has scientific collaborations with the University of Virginia and Anandia Laboratories, Inc. to develop proprietary hemp strains with less than 0.3% dry weight content of delta-9-tetrahydrocannabinol. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.
Cap:
|
Volume (24h):